In-vitro Bactericidal Activity of Colistin Against Biofilm-Associated Pseudomonas Aeruginosa and Acinetobacter Baumannii

Y Cai,R Wang,B-B Liang,M-M An
DOI: https://doi.org/10.1016/j.jhin.2009.03.013
2009-01-01
Abstract:Pseudomonas aeruginosa and Acinetobacter baumannii are of concern as nosocomial pathogens and cause a wide spectrum of infection from skin and wound infections to septicaemia. 1 Navon-Venezia S. Ben-Ami R. Carmeli Y. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis. 2005; 18: 306-313 Crossref PubMed Scopus (193) Google Scholar In addition, multiple drug-resistant (MDR) strains and even pan-resistant strains are evolving and spreading, while few new antibacterial agents are being developed in parallel. 2 Kwa A.L. Tam V.H. Falagas M.E. Polymyxins: a review of the current status including recent developments. Ann Acad Med Singap. 2008; 37: 870-883 PubMed Google Scholar As a result, a re-evaluation of polymyxins has taken place and these agents may be a last resort for MDR Gram-negative infections, even though their use in clinical practice was discontinued due to adverse renal and neurological effects in a large number of patients. Biofilm is one of the important mechanisms of persistence of drug-resistant organisms and both P. aeruginosa and A. baumannii can form typical biofilms. 3 Sauer K. Camper A.K. Ehrlich G.D. Costerton J.W. Davies D.G. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol. 2002; 184: 1140-1154 Crossref PubMed Scopus (1205) Google Scholar , 4 Cevahir N. Demir M. Kaleli I. Gurbuz M. Tikvesli S. Evaluation of biofilm production, gelatinase activity, and mannose-resistant hemagglutination in Acinetobacter baumannii strains. J Microbiol Immunol Infect. 2008; 41: 513-518 PubMed Google Scholar Therefore, we evaluated the in-vitro bactericidal activity of colistin against different stages of biofilms of these two species.
What problem does this paper attempt to address?